0001628280-24-004120.txt : 20240209 0001628280-24-004120.hdr.sgml : 20240209 20240209170904 ACCESSION NUMBER: 0001628280-24-004120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waters Kevin CENTRAL INDEX KEY: 0001653771 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 24616072 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 6502329832 MAIL ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 wk-form4_1707516534.xml FORM 4 X0508 4 2024-02-07 0 0001588978 PROCEPT BioRobotics Corp PRCT 0001653771 Waters Kevin C/O PROCEPT BIOROBOTICS CORPORATION 150 BAYTECH DRIVE SAN JOSE CA 95134 0 1 0 0 EVP, CFO 1 Common Stock 2024-02-07 4 M 0 904 4.52 A 34427 D Common Stock 2024-02-07 4 S 0 904 50 D 33523 D Common Stock 2024-02-09 4 M 0 28677 4.52 A 62200 D Common Stock 2024-02-09 4 S 0 28677 50.0882 D 33523 D Stock Option (Right to Buy) 4.52 2024-02-07 4 M 0 904 0 D 2028-10-22 Common Stock 904 102953 D Stock Option (Right to Buy) 4.52 2024-02-09 4 M 0 28677 0 D 2028-10-22 Common Stock 28677 74276 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The Stock Option was granted on October 23, 2018 and vested over a four year period. /s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters 2024-02-09